A trial emulation assessed whether GLP-1RA use improves cardiovascular, kidney, and death outcomes in patients with systemic lupus erythematosus, including lupus nephritis.

GLP-RAs significantly improved liver histology, liver fat, and metabolic markers in patients with MASLD, outperforming DDP-4 inhibitors but increasing mild GI side effects.

Maureen McCormack of Esker, Co Offaly, pleaded guilty to arson at the Bank of Ireland branch in the town on October 6th, 2021 ...

LIVE: Connolly and Humphreys are going head to head in the final Áras debate When Heath Ledger’s housekeeper discovered his lifeless body, the first call she made was not for an ambulance, it was to ...

The permitting director insists the new program is working and problems are being fixed, but some staff are begging for a ...

A man who assaulted a nine-week-old baby during a home invasion in Alice Springs last year has been sentenced to a two-year ...

President Peter Mutharika has given insights on the 12-year free-cycle of education, saying it covers examination fees, ...

Conservative Sanae Takaichi, leader of Japan's LDP, became the country's 104th prime minister and the first woman to hold the ...

In a study from Korea, adults with type 2 diabetes had a lower risk for autoimmune rheumatic diseases after starting an SGLT2 ...

Hot on the heels of their army set, new Helsmiths of Hashut Army Units get - and a full battletome - bring fire to Age of ...

The collapse of the China spying case has effectively “killed” some active operations because details of the case have been ...